Problem:Cardiovascular risk reduction in obesity
Unchecked
From Pharmacopedia
More actions
This page is early; a full clinical description is coming. The cross-linked medicines below are live.
Reduction of MACE in adults with obesity but without type 2 diabetes (SELECT trial indication).